Risk Models for Advanced Melanoma Patients Under Anti-PD-1 Monotherapy—Ad hoc Analyses of Pooled Data From Two Clinical Trials

MLA

Xue Bai, et al. “Risk Models for Advanced Melanoma Patients Under Anti-PD-1 Monotherapy—Ad Hoc Analyses of Pooled Data From Two Clinical Trials.” Frontiers in Oncology, vol. 11, May 2021. EBSCOhost, https://doi.org/10.3389/fonc.2021.639085.

APA

Xue Bai, Jie Dai, Caili Li, Chuanliang Cui, Lili Mao, Xiaoting Wei, Xinan Sheng, Zhihong Chi, Xieqiao Yan, Bixia Tang, Bin Lian, Xuan Wang, Li Zhou, Siming Li, Yan Kong, Zhonghui Qi, Huayan Xu, Rong Duan, Jun Guo, & Lu Si. (2021). Risk Models for Advanced Melanoma Patients Under Anti-PD-1 Monotherapy—Ad hoc Analyses of Pooled Data From Two Clinical Trials. Frontiers in Oncology, 11. https://doi.org/10.3389/fonc.2021.639085

Chicago

Xue Bai, Jie Dai, Caili Li, Chuanliang Cui, Lili Mao, Xiaoting Wei, Xinan Sheng, et al. 2021. “Risk Models for Advanced Melanoma Patients Under Anti-PD-1 Monotherapy—Ad Hoc Analyses of Pooled Data From Two Clinical Trials.” Frontiers in Oncology 11 (May). doi:10.3389/fonc.2021.639085.